-
oa Deciphering the Key Toxicants and Hepatotoxicity Mechanisms of Epimedii Folium and its Preparations via Network Toxicology and Molecular Docking
-
-
- 08 Sep 2025
- 29 Oct 2025
- 08 Jan 2026
Abstract
The key toxicological constituents and mechanisms of Epimedii Folium and its formulations, such as Xianling Gubao Capsules (XLGB) and Zhuanggu Guanjie Pills (ZGGJ), remain insufficiently understood, particularly when used in combination. The objective of this study is to investigate the hepatotoxic effects and mechanisms of Epimedii Folium and its formulations, XLGB and ZGGJ, using network toxicology, molecular docking, and in vitro validation.
Potential hepatotoxic components and targets of Epimedii Folium, XLGB, and ZGGJ were screened from multiple databases. PPI networks were constructed, and GO/KEGG enrichment analyses were performed. Molecular docking was used to assess the binding affinities between key components and core targets. In vitro validation was conducted using HepG2 cells to assess cell viability and ROS levels through CCK-8 and HCS assays, respectively.
This study confirms that Sagittatoside A, Epimedin B, and Icariside I are the primary hepatotoxic constituents of Epimedii Folium, capable of targeting core pathways involving KDR, AR, PTGS2, F7, and DPP4. Furthermore, Sagittatoside A and Icariside I significantly elevated ROS levels. The toxic constituents of XLGB and ZGGJ overlapped with those of Epimedii Folium, and Bavachinin and Neobavaisoflavone from PCL were found to exert synergistic hepatotoxic effects. Neobavaisoflavone enhanced the hepatotoxicity of Epimedin B and Icariside I, while Bavachinin showed synergistic toxicity when combined with Sagittatoside A.
Molecular docking confirmed strong binding affinities between these compounds and their targets. In vitro experiments demonstrated that Sagittatoside A and Icariside I significantly increased ROS levels. The compound formulations XLGB and ZGGJ shared similar hepatotoxic components and mechanisms. Additionally, Bavachinin and Neobavaisoflavone from PCL synergistically enhanced the hepatotoxicity of Epimedii Folium monomers, providing a modern scientific basis for evaluating compatibility principles in traditional Chinese medicine.
This study comprehensively elucidates the hepatotoxicity and synergistic toxic effects of Epimedii Folium and its formulations XLGB and ZGGJ, offering a modern scientific rationale to guide the safe formulation and compatibility of traditional Chinese medicine.